This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kirsch, J. R. Articles by D'Alecy, L. G. Search for Related Content PubMed PubMed Citation Articles by Kirsch, J. R. Articles by D'Alecy, L. G.

Stroke, Vol 14, 971-976, Copyright © 1983 by American Heart Association

ARTICLES

Role of tissue lactate and substrate availability in 1,3-butanediol- enhanced hypoxic survival in the mouse

JR Kirsch and LG D'Alecy

Previously we found that 1,3-butanediol-treated mice live longer during hypoxia. We hypothesized that 1,3-butanediol could reduce the brain's accumulation of potentially cytotoxic lactate and/or elevate brain substrate availability (ketones or glucose) and thus maintain the brain's energy producing capability even during reduced oxygen availability. To test these hypotheses, whole brain metabolites from normoxic and hypoxic mice, pretreated with 1,3-butanediol or insulin, were compared to saline controls. During hypoxia both pretreated groups had lower brain lactate than controls. If lactate accumulation was the sole factor responsible for hypoxic tolerance, insulin should have increased brain lactate since insulin has been shown previously to reduce hypoxic tolerance. In normoxic mice the ratio of lactate to pyruvate and the level of malate and fumarate were not changed by 1,3- butanediol as is found with other agents known to protect the hypoxic animal. When substrate availability was directly elevated by beta- hydroxybutyrate and glucose administration hypoxic survival time increased thus implicating substrate availability as an important factor in hypoxic tolerance. We conclude that reduced brain lactate and augmented substrate availability both contribute to 1,3-butanediol- enhanced hypoxic tolerance in this animal model.

This article has been cited by other articles:

				C. F. Zwemer, M. Y. Song, K. A. Carello, and L. G. D'Alecy Strain differences in response to acute hypoxia: CD-1 versus C57BL/6J mice J Appl Physiol, January 1, 2007; 102(1): 286 - 293. [Abstract] [Full Text] [PDF]